2022 ICD-10-CM Code D86
Sarcoidosis
Not Valid for Submission
| ICD-10: | D86 |
| Short Description: | Sarcoidosis |
| Long Description: | Sarcoidosis |
Code Classification
D86 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of sarcoidosis. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding for Sarcoidosis
Non-specific codes like D86 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for sarcoidosis:
- BILLABLE CODE - Use D86.0 for Sarcoidosis of lung
- BILLABLE CODE - Use D86.1 for Sarcoidosis of lymph nodes
- BILLABLE CODE - Use D86.2 for Sarcoidosis of lung with sarcoidosis of lymph nodes
- BILLABLE CODE - Use D86.3 for Sarcoidosis of skin
- NON-BILLABLE CODE - D86.8 for Sarcoidosis of other sites
- BILLABLE CODE - Use D86.81 for Sarcoid meningitis
- BILLABLE CODE - Use D86.82 for Multiple cranial nerve palsies in sarcoidosis
- BILLABLE CODE - Use D86.83 for Sarcoid iridocyclitis
- BILLABLE CODE - Use D86.84 for Sarcoid pyelonephritis
- BILLABLE CODE - Use D86.85 for Sarcoid myocarditis
- BILLABLE CODE - Use D86.86 for Sarcoid arthropathy
- BILLABLE CODE - Use D86.87 for Sarcoid myositis
- BILLABLE CODE - Use D86.89 for Sarcoidosis of other sites
- BILLABLE CODE - Use D86.9 for Sarcoidosis, unspecified
Clinical Information
- SARCOIDOSIS-. an idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. it usually invades the lungs with fibrosis and may also involve lymph nodes skin liver spleen eyes phalangeal bones and parotid glands.
- SARCOIDOSIS PULMONARY-. sarcoidosis affecting predominantly the lungs the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar bronchial and vascular walls composed of tightly packed cells derived from the mononuclear phagocyte system. the clinical symptoms when present are dyspnea upon exertion nonproductive cough and wheezing. cecil textbook of medicine 19th ed p431
Information for Patients
Sarcoidosis
Sarcoidosis is a disease that leads to inflammation, usually in your lungs, skin, or lymph nodes. It starts as tiny, grain-like lumps, called granulomas. Sarcoidosis can affect any organ in your body.
No one is sure what causes sarcoidosis. It affects men and women of all ages and races. It occurs mostly in people ages 20 to 50, African Americans, especially women, and people of Northern European origin.
Many people have no symptoms. If you have symptoms, they may include
- Cough
- Shortness of breath
- Weight loss
- Night sweats
- Fatigue
Tests to diagnose sarcoidosis include chest x-rays, lung function tests, and a biopsy. Not everyone who has the disease needs treatment. If you do, prednisone, a type of steroid, is the main treatment.
NIH: National Heart, Lung, and Blood Institute
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)